In the current study, we found that mice engineered to express U2AF1-S34F but not wild type U2AF1 exhibit a profound immunodeficiency, likely due to neutrophil chemotaxis defects induced by this MDS-associated spliceosome mutation. This evidence concerns the gene U2AF1 and myelodysplastic syndrome.